Akademska digitalna zbirka SLovenije - logo
E-resources
Peer reviewed Open access
  • Interaction of tau with the...
    Vanderweyde, Tara; Apicco, Daniel J.; Youmans-Kidder, Katherine; Ash, Peter E.A.; Cook, Casey; Lummertz da Rocha, Edroaldo; Jansen-West, Karen; Frame, Alissa A.; Citro, Allison; Leszyk, John D.; Ivanov, Pavel; Abisambra, Jose F.; Steffen, Martin; Li, Hu; Petrucelli, Leonard; Wolozin, Benjamin

    Cell reports (Cambridge), 05/2016, Volume: 15, Issue: 7
    Journal Article

    Dendritic mislocalization of microtubule associated protein tau is a hallmark of tauopathies, but the role of dendritic tau is unknown. We now report that tau interacts with the RNA-binding protein (RBP) TIA1 in brain tissue, and we present the brain-protein interactome network for TIA1. Analysis of the TIA1 interactome in brain tissue from wild-type (WT) and tau knockout mice demonstrates that tau is required for normal interactions of TIA1 with proteins linked to RNA metabolism, including ribosomal proteins and RBPs. Expression studies show that tau regulates the distribution of TIA1, and tau accelerates stress granule (SG) formation. Conversely, TIA1 knockdown or knockout inhibits tau misfolding and associated toxicity in cultured hippocampal neurons, while overexpressing TIA1 induces tau misfolding and stimulates neurodegeneration. Pharmacological interventions that prevent SG formation also inhibit tau pathophysiology. These studies suggest that the pathophysiology of tauopathy requires an intimate interaction with RNA-binding proteins. Display omitted •Tau is required for normal interactions of RNA binding proteins in brain tissue•Tau promotes stress granules, while TIA1 promotes tau misfolding and insolubility•TIA1 knockdown or knockout inhibits tau pathology and toxicity•TIA1 and tau act synergistically to modulate degeneration of cultured neurons Vanderweyde et al. show that the interaction of microtubule associated protein tau with the RNA binding protein (RBP) TIA1 regulates stress granule (SG) formation as well as misfolding and aggregation of tau. TIA1 knockdown prevents tau misfolding and tau-mediated toxicity, which points to RBPs as potential targets for therapy of tauopathies.